Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H28N2O5S |
Molecular Weight | 468.565 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC=C(CN(CC2=CC(OCC(O)=O)=CC=C2)S(=O)(=O)C3=CN=CC=C3)C=C1
InChI
InChIKey=WOHRHWDYFNWPNG-UHFFFAOYSA-N
InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29)
Evatanepag (CP-533,536) is a prostaglandin E2 EP2 receptor agonist. It stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing. Evatanepag was under development with Pfizer as a bone formation stimulant for therapeutic use in the healing of fractures.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1881 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24279689 |
5.0 nM [EC50] |
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20945000
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
223488-57-1
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
DB12022
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
C83707
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
300000034247
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
9151
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
9890801
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
UU-103
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
L266R6E31E
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL563646
Created by
admin on Fri Dec 15 16:25:09 GMT 2023 , Edited by admin on Fri Dec 15 16:25:09 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
SALT/SOLVATE (PARENT)